Design, Synthesis, and Antitumor Activity Evaluation of Novel VISTA Small Molecule Inhibitors

Author:

Sun Chengliang123,He Yuling14,Wang Gefei123,Zhang Guoyu123,Zhang Yu14,Shen Hao123,Hu Lingrong123,Sun Yanze123,Jiang Binjian123,Wang Xiao123,Yuan Kai123ORCID,Min Wenjian123,Wang Liping123,Sun Haopeng2,Xiao Yibei145,Yang Peng123ORCID

Affiliation:

1. State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China

2. Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China

3. Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, Nanjing 211198, China

4. Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China

5. Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China

Funder

National Key Research and Development Program of China

State Key Laboratory of Natural Medicines

China Pharmaceutical University

Double First Class University Plan

China Postdoctoral Science Foundation

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3